Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3244.5
(0.37%)
INR 3244.5
(0.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 22.79 Billion INR | 2.21% |
| 2022 | 22.29 Billion INR | -9.45% |
| 2021 | 24.62 Billion INR | -8.16% |
| 2020 | 26.81 Billion INR | 24.81% |
| 2019 | 21.48 Billion INR | 11.01% |
| 2018 | 19.35 Billion INR | -1.58% |
| 2017 | 19.66 Billion INR | 26.11% |
| 2016 | 15.59 Billion INR | 14.81% |
| 2015 | 13.57 Billion INR | 27.25% |
| 2014 | 10.67 Billion INR | 6.07% |
| 2013 | 10.06 Billion INR | 8.9% |
| 2012 | 9.23 Billion INR | 73.8% |
| 2011 | 5.31 Billion INR | 5.29% |
| 2010 | 5.04 Billion INR | 55.99% |
| 2009 | 3.23 Billion INR | 22.34% |
| 2008 | 2.64 Billion INR | 14.53% |
| 2007 | 2.3 Billion INR | -10.52% |
| 2006 | 2.58 Billion INR | 14.55% |
| 2005 | 2.25 Billion INR | 51.91% |
| 2004 | 1.48 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 22.71 Billion INR | 0.0% |
| 2023 FY | 22.79 Billion INR | 2.21% |
| 2023 Q2 | 22.18 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 22.79 Billion INR | 0.0% |
| 2022 Q2 | 23.28 Billion INR | 0.0% |
| 2022 FY | 22.29 Billion INR | -9.45% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 22.29 Billion INR | 0.0% |
| 2021 FY | 24.62 Billion INR | -8.16% |
| 2021 Q2 | 26.12 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 24.62 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 25.41 Billion INR | 0.0% |
| 2020 FY | 26.81 Billion INR | 24.81% |
| 2020 Q4 | 26.81 Billion INR | 0.0% |
| 2019 Q4 | 21.48 Billion INR | 0.0% |
| 2019 FY | 21.48 Billion INR | 11.01% |
| 2019 Q2 | 19.6 Billion INR | 0.0% |
| 2018 Q4 | 19.35 Billion INR | 0.0% |
| 2018 Q2 | 20.33 Billion INR | 0.0% |
| 2018 FY | 19.35 Billion INR | -1.58% |
| 2017 FY | 19.66 Billion INR | 26.11% |
| 2017 Q4 | 19.66 Billion INR | 0.0% |
| 2017 Q2 | 15.43 Billion INR | 0.0% |
| 2016 Q4 | 15.59 Billion INR | 0.0% |
| 2016 FY | 15.59 Billion INR | 14.81% |
| 2016 Q2 | 15.82 Billion INR | 0.0% |
| 2015 Q4 | 13.57 Billion INR | 0.0% |
| 2015 Q2 | 12.11 Billion INR | 0.0% |
| 2015 FY | 13.57 Billion INR | 27.25% |
| 2014 Q2 | 10.24 Billion INR | 0.0% |
| 2014 Q4 | 10.67 Billion INR | 0.0% |
| 2014 FY | 10.67 Billion INR | 6.07% |
| 2013 Q2 | 9.98 Billion INR | 0.0% |
| 2013 Q4 | 10.06 Billion INR | 0.0% |
| 2013 FY | 10.06 Billion INR | 8.9% |
| 2012 Q4 | 9.23 Billion INR | 0.0% |
| 2012 FY | 9.23 Billion INR | 73.8% |
| 2011 Q4 | 5.31 Billion INR | 0.0% |
| 2011 FY | 5.31 Billion INR | 5.29% |
| 2010 FY | 5.04 Billion INR | 55.99% |
| 2009 FY | 3.23 Billion INR | 22.34% |
| 2008 FY | 2.64 Billion INR | 14.53% |
| 2007 FY | 2.3 Billion INR | -10.52% |
| 2006 FY | 2.58 Billion INR | 14.55% |
| 2005 FY | 2.25 Billion INR | 51.91% |
| 2004 FY | 1.48 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -38.664% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 76.764% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -241.889% |
| Granules India Limited | 13 Billion INR | -75.234% |
| Indoco Remedies Limited | 3.53 Billion INR | -545.499% |
| Achyut Healthcare Limited | 568 Thousand INR | -4012223.944% |
| Ajanta Pharma Limited | 8.28 Billion INR | -175.122% |
| Alkem Laboratories Limited | 26.61 Billion INR | 14.361% |
| Alpa Laboratories Limited | 136.65 Million INR | -16577.277% |
| Brooks Laboratories Limited | 96.1 Million INR | -23612.906% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -900.079% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -1482.219% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -1824.062% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 64.14% |
| Eris Lifesciences Limited | 1.89 Billion INR | -1105.616% |
| FDC Limited | 3.88 Billion INR | -486.029% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 9.313% |
| Gufic Biosciences Limited | 2 Billion INR | -1036.76% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -21692.555% |
| Ipca Laboratories Limited | 24.71 Billion INR | 7.782% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -15096.373% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -23163.648% |
| Lasa Supergenerics Limited | 190.43 Million INR | -11867.401% |
| Laurus Labs Limited | 18.45 Billion INR | -23.496% |
| Lupin Limited | 49.53 Billion INR | 53.996% |
| Mankind Pharma Limited | 15.53 Billion INR | -46.705% |
| Medicamen Biotech Limited | 593.75 Million INR | -3738.303% |
| Medico Remedies Limited | 163.37 Million INR | -13849.759% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -225.339% |
| Piramal Pharma Limited | 21.75 Billion INR | -4.739% |
| RPG Life Sciences Limited | 1.01 Billion INR | -2156.436% |
| Sigachi Industries Limited | 707.2 Million INR | -3122.536% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 76.906% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -885.745% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -10710.426% |
| Unichem Laboratories Limited | 7.04 Billion INR | -223.411% |
| Wanbury Limited | 360.23 Million INR | -6226.478% |
| Windlas Biotech Limited | 621.89 Million INR | -3564.635% |
| ZIM Laboratories Limited | 812.62 Million INR | -2704.478% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 33.787% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 28.423% |
| Hester Biosciences Limited | 755.81 Million INR | -2915.308% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -1988.718% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -7784.531% |
| Bal Pharma Limited | 878.11 Million INR | -2495.335% |
| Strides Pharma Science Limited | 11.26 Billion INR | -102.355% |
| Venus Remedies Limited | 1.21 Billion INR | -1772.792% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -254.51% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -221.37% |
| Shilpa Medicare Limited | 3.44 Billion INR | -560.717% |
| Aarti Drugs Limited | 4.85 Billion INR | -369.036% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -436.437% |
| Suven Life Sciences Limited | 7.08 Million INR | -321565.49% |
| Ind-Swift Limited | 640.91 Million INR | -3455.854% |
| Valiant Laboratories Limited | 100.15 Million INR | -22654.957% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -353.523% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -533.584% |
| Themis Medicare Limited | 705.74 Million INR | -3129.221% |
| Hikal Limited | 3.03 Billion INR | -650.362% |
| Sequent Scientific Limited | 3.46 Billion INR | -558.229% |
| Novartis India Limited | 448.6 Million INR | -4980.25% |
| Wockhardt Limited | 6.4 Billion INR | -256.094% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -76.721% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -89283.065% |
| Neuland Laboratories Limited | 3.5 Billion INR | -550.359% |
| Morepen Laboratories Limited | 2.48 Billion INR | -816.755% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -57046.439% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -1743.258% |